Ethyl (Z)-5-((1H-pyrrolo[3,2-b]pyridin-2-yl)methylene)-4-oxo-2-(phenylamino)-4,5-dihydrothiophene-3-carboxylate

ID: ALA5195225

PubChem CID: 168289936

Max Phase: Preclinical

Molecular Formula: C21H17N3O3S

Molecular Weight: 391.45

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CCOC(=O)C1=C(Nc2ccccc2)S/C(=C\c2cc3ncccc3[nH]2)C1=O

Standard InChI:  InChI=1S/C21H17N3O3S/c1-2-27-21(26)18-19(25)17(28-20(18)24-13-7-4-3-5-8-13)12-14-11-16-15(23-14)9-6-10-22-16/h3-12,23-24H,2H2,1H3/b17-12-

Standard InChI Key:  BXSRZRACIZHJET-ATVHPVEESA-N

Molfile:  

 
     RDKit          2D

 28 31  0  0  0  0  0  0  0  0999 V2000
    0.1515   -0.0889    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5159    0.3960    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2609    1.1807    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5640    1.1807    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8190    0.3960    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6157    0.1825    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.8292   -0.6142    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6260   -0.8280    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8381   -1.6225    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2547   -2.2061    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4614   -1.9951    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2435   -1.2001    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9764    1.8951    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5640    2.6095    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.9764    3.3239    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8013    3.3239    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8013    1.8951    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6734    1.8951    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3127    0.1825    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5262   -0.6142    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0073   -1.2550    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4564   -1.9465    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2528   -1.7331    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2959   -0.9097    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2442   -2.7406    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8271   -3.3239    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6200   -3.1133    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8381   -2.3188    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  1  1  0
  5  6  1  0
  6  7  1  0
  8  7  2  0
  9  8  1  0
 10  9  2  0
 11 10  1  0
 12 11  2  0
  7 12  1  0
  4 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 13 17  2  0
  3 18  2  0
  2 19  2  0
 19 20  1  0
 21 20  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 20  1  0
 22 25  1  0
 26 25  2  0
 27 26  1  0
 28 27  2  0
 23 28  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5195225

    ---

Associated Targets(Human)

JAR (316 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
K562 (73714 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 391.45Molecular Weight (Monoisotopic): 391.0991AlogP: 4.11#Rotatable Bonds: 5
Polar Surface Area: 84.08Molecular Species: NEUTRALHBA: 6HBD: 2
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 11.04CX Basic pKa: 4.43CX LogP: 3.91CX LogD: 3.91
Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.39Np Likeness Score: -1.13

References

1. Hwang J, Qiu X, Borgelt L, Haacke N, Kanis L, Petroulia S, Gasper R, Schiller D, Lampe P, Sievers S, Imig J, Wu P..  (2022)  Synthesis and evaluation of RNase L-binding 2-aminothiophenes as anticancer agents.,  58  [PMID:35152173] [10.1016/j.bmc.2022.116653]
2. Duvauchelle V, Meffre P, Benfodda Z..  (2022)  Recent contribution of medicinally active 2-aminothiophenes: A privileged scaffold for drug discovery.,  238  [PMID:35696863] [10.1016/j.ejmech.2022.114502]

Source